Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference

Audio By Carbonatix

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Nov 5, 2025--

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the Piper Sandler 37 th Annual Healthcare Conference on Wednesday, December 3, 2025, at 10:30 a.m. ET at the Lotte Palace in New York, NY.

Presentation Information
A live and recorded webcast of the presentation will be available at:
https://event.webcasts.com/starthere.jsp?ei=1742138&tp_key=f2a06e9abc

About Adagio Medical Holdings, Inc.

Adagio is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular arrhythmias with its purpose-built vCLAS™ Cryoablation System, which is CE Marked and is currently under evaluation in the Company’s FULCRUM-VT U.S. IDE Pivotal Study.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251105837821/en/

CONTACT: Debbie Kaster

Chief Financial Officer and Chief Business Officer

[email protected]

KEYWORD: CALIFORNIA NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH MEDICAL DEVICES

SOURCE: Adagio Medical Holdings, Inc.

Copyright Business Wire 2025.

PUB: 11/05/2025 08:00 AM/DISC: 11/05/2025 08:01 AM

http://www.businesswire.com/news/home/20251105837821/en